If you need help accessing our website, call 855-698-9991
Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.

Anam Qureshi, MD

Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.
  • Specialties: Ophthalmology, Cornea External Disease & Refractive Surgery
  • Treats: Adults
  • Languages: English, Urdu
  • Phone: 212-448-0101
View Locations

Conditions and Treatments

For Adults
Conditions
  • abnormal eye pressure
  • astigmatism
  • blepharitis
  • blurred vision
  • cataract
  • chalazion
  • cloudy vision
  • conjunctivitis
  • corneal abrasion
  • corneal disease
  • corneal ulcer
  • diabetes
  • diabetic retinopathy
  • dislocated intraocular lens
  • distorted vision
  • double vision
  • dry eye syndrome
  • excessive tearing
  • exfoliation syndrome
  • eye floater
  • eye infection
  • eye injury
  • eye pain
  • eye redness
  • facial spasm
  • fuchs' dystrophy
  • glaucoma
  • halo vision
  • hyperopia
  • hyperthyroidism
  • keratoconus
  • lazy eye
  • macular degeneration
  • meibomian gland dysfunction
  • myopia
  • night blindness
  • ocular herpes
  • presbyopia
  • pterygium
  • refractive error
  • rosacea
  • sicca syndrome
  • stye
  • sudden loss of vision
  • thyroid disorder
  • traumatic fracture
  • trichiasis
  • uveitis
  • watery eye
Treatments
  • cataract removal surgery
  • color vision test
  • corneal collagen cross-linking
  • corneal transplant
  • descemet membrane endothelial keratoplasty (DMEK)
  • descemet stripping automated endothelial keratoplasty (DSAEK)
  • endothelial keratoplasty
  • fixated intraocular lens
  • laser surgery
  • lasik surgery
  • photorefractive keratectomy
  • refractive surgery
View All Conditions and Treatments
Learn more about conditions we treat at NYU Langone:
Cataract , Conjunctivitis , Double Vision , Dry Eye Syndrome , Glaucoma , Hyperthyroidism , Lazy Eye , Macular Degeneration , Refractive Error , Rosacea , Stye , Thyroid Nodules & Cancers

Positions
Board Certifications
  • American Board of Ophthalmology - Ophthalmology, 2017
Education and Training
  • Fellowship, Emory University, Cornea, External Disease, and Refractive Surgery, 2016
  • Residency, NYU Langone Medical Center, Ophthalmology, 2015
  • MD from Jefferson Medical College, 2011

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

  • Empire Blue Cross Blue Shield
     
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
    • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Local 1199
     
    • Local 1199 PPO
  • MagnaCare
     
    • MagnaCare PPO
  • NYS Health Insurance Plan
     
    • The Empire Plan
  • Oxford
     
    • Oxford Freedom
    • Oxford Liberty
    • Oxford Medicare
  • UHC
     
    • UnitedHealthcare EPO
    • UnitedHealthcare HMO
    • UnitedHealthcare Medicare
    • UnitedHealthcare POS
    • UnitedHealthcare PPO
    • UnitedHealthcare Top Tier
View All Accepted Plans This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Anam Qureshi, MD does not accept insurance.

Locations and Appointments

Madison Ophthalmology PLLC

161 Madison Avenue, Ste 5SE, New York, NY 10016

View Map
Phone

212-448-0101

Fax

212-448-0116

These focus areas and their associated publications are derived from PubMed and the MeSH term library. *
represents one publication
Loading...
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

  • A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation

    Learn More

  • A Phase 1/2 First-in-Human Study of DCC-3116 as Monotherapy and in Combination with RAS/MAPK Pathway Inhibitors in Patients with Advanced or Metastatic Solid Tumors with RAS/MAPK Pathway Mutations

    Learn More

  • A Phase 1 Multicenter Dose Escalation and Dose Expansion Study of Antibody-Drug Conjugate MYTX-011 in Subjects with Non-Small Cell Lung Cancer KisMET-01

    Learn More
View All Research Studies (5)

  • Safety of reduced infusion times for nivolumab plus ipilimumab (N + I) and nivolumab alone (N) in advanced melanoma

    Martin-Algarra, S; Haanen, J B; Horak, C; Bhatia, S; Ribas, A; Hwu, W -J; Slingluff,, C L; Sharfman, W H; Callahan, M; Hodi, F S; Wolchok, J D; Luke, J; Young, T C; Qureshi, A; Urba, W J

    Annals of oncology. 2016 October 1; 27(Supplement):vi385

  • Recurrent C. difficile in a Patient with IgG Deficiency 

    Jehangir, Asad; Bennett, Kyle; Fareedy, Shoaib Bilal; Rettew, Andrew; Shaikh, Bilal; Qureshi, Anam; Jehangir, Qasim; Alweis, Richard

    Case reports in gastrointestinal medicine. 2015 May ; 2015:356293

  • Epibulbar osseous choristoma in 8 patients 

    Shields, Carol L; Qureshi, Anam; Eagle, Ralph C Jr; Lally, Sara E; Shields, Jerry A

    Cornea. 2012 Jul ; 31(7):756-60

Read All Publications (6)